Morning all!

Innovaderma ( Innovaderma (LON:IDP) ) – 168p – £24.2m – PER 22.7

Final Results For The 12 Months To End June 2018 – Revenue up 21% to £10.7m (FY2017: £8.9m), PBT £0.67m (FY2017: £1.03m) due to one off investments. Net Cash of £1.9m (as at 30 June 2017: £0.21m). Note: Skinny Tan is going into Boots, 1,000+ stores in Q1 2019 (joining Superdrug). Strong growth expected in 2019.

Will keep this on my Watchlist to keep an eye out for updates – Really needs to start improving not just Revenues but PBT and EPS too, but this is perhaps now due.

Alliance Pharma ( Alliance Pharma (LON:APH) ) – 91p – £468.8m – PER 18.3

Interim Results For The 6 Months To End June 2018 – Revenue up 10% (12% CC) with Underlying Basic EPS up 4%, Net Debt stands at £86.3m, £72.3m last time. The Interim Dividend is up 10% to 0.487p.

On a PER of almost 20 I remain Neutral for now.

Cello ( Cello Health (LON:CLL) ) – 133p – £139.3m – PER 14.9

Interim Results For The 6 Months To End June 2018 – Revenue flat, with Statutory PBT up 23.5% and Statutory Basic EPS up 9.3%. Net Debt is down about 10% and the Interim Dividend is up 4.8%.

I said this last time “Seems like an OK company but there’s not enough here to make me want to invest at present”, I will remain Neutral.

Elektron Technology ( Elektron Technology (LON:EKT) ) – 48.5p – £90.3m – PER 30.7

Interim Results For The 6 Months To End July 2018 – Revenue up 17% to £15.9m, Operating Profit up 180% to £1.4m (H1 FY18: £0.5m), Net Cash at £6.8m (31 July 2017: £2.1m; 31 January 2018: £5.2m). Positive outlook for H2 and beyond, FY to be in-line with recently upgraded expectations.

I am tempted here, it’s going on my Watchlist – Forecasts look good, even on a PER of 30 or so, perhaps it’s time to take the plunge!

Quixant ( Quixant (LON:QXT) ) – 479p – £317.8m –…

Unlock this Article with a 14 day free trial

or Unlock with your email

Already have an account?
Login here